Trident Lifeline has made further Investment by acquiring an additional equity stake of 9.04% of Trident Mediquip (TML), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in TML has increased from 51% to 60.04%. Cost of acquisition is around Rs 4.42 crore.
Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.